Most of the reports regarding FGFR4 and cancers have focused mainly on a common single-nucleotide polymorphism (SNP), FGFR4 Gly388Arg, of which at least one copy is present in approximately 30– 50% of the population [13, 55]. This evidence concerns the gene FGFR4 and cancer.